Driven by ongoing reform and cost pressures, the U.S. health care system is undergoing multiple, simultaneous changes that are affecting the way providers, payers, and patients do business. What’s more, the rapid changes give unprecedented opportunity for pathologists and laboratories alike to provide leadership in driving coordinated care. This year’s Lab Institute, “Inflection Point for Labs,” will tackle the challenges facing clinical and anatomic pathology laboratories and provide solutions and strategies for labs to survive and thrive in these transformational times. Be sure to join more than 400 of your colleagues in Washington, D.C., Oct. 15-17 for this critical event. In the opening keynote session, G2 founder Dennis Weissman and Marc Grodman, chairman, president, and CEO of BioReference Laboratories, will discuss the top market challenges Grodman sees for the lab sector, including continued reimbursement pressure by government and private payers, and the advent of new delivery and payment systems emerging around the country. In the second keynote address, James Crawford, M.D., Ph.D., executive director and senior vice president for laboratory services at North Shore-LIJ Health System, will examine how the lab industry can leverage its massive data streams to drive improved patient outcomes and the delivery of cost-effective care, as…
